- Business Wire•10 days agoGuided Therapeutics Reports Second Quarter 2016 Financial Results; Year to Date Revenue Up 71% Over Same Period Last Year
Guided Therapeutics, Inc. , developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care, today announced financial results for the second quarter 2016.
- Business Wire•last monthGuided Therapeutics Ships Additional LuViva® Advanced Cervical Scan Systems and Disposables to Bangladesh
Guided Therapeutics, Inc. , the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it shipped four additional LuViva® Advanced Cervical Scan systems to Bangladesh for use in the country’s cervical cancer screening program.
- Business Wire•last month
Guided Therapeutics, Inc. , the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it has sold the first LuViva® Advanced Cervical Scan to its distributor in Russia.
Guided Therapeutics, Inc (GTHP)
OTC BB - OTC BB Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|52wk Range||0.00 - 0.18|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.00|
|Avg Vol (3m)||7,051,455|
|Dividend & Yield||N/A (N/A)|